Over the past five years leading to 2021, fintech disruption has reshaped healthcare finance across many emerging market economies, creating new access points for low- and middle-income households that were locked out of traditional financial services. In most of these markets, over 60% of working-age adults lack formal bank accounts or credit lines, making it impossible to cover unexpected medical costs that often push families into poverty. Central banks in these regions have gradually loosened regulatory constraints on fintech lending to encourage financial inclusion, creating space for specialized platforms to fill the gap between public healthcare systems and patient needs. A 2020 study by the World Bank found that fintech healthcare microloans reduced the rate of medical debt in major Southeast Asian emerging markets by 18% between 2016 and 2020, even amid monetary policy tightening that led to temporary yield curve inversion and reduced liquidity in mainstream credit markets. Unlike traditional banks, which rely on rigid credit scoring models that exclude unbanked households, fintech platforms use alternative data from mobile payment histories to assess borrower risk. This approach cuts approval times from three days to less than 15 minutes, making it suitable for emergency medical expenses that require immediate funding. A leading fintech platform focusing on healthcare finance in India, established in 2017, reports that 72% of its users have never held a formal bank account, and 84% say they would not have been able to access care without its microloan products. Dr. Priya Mehta, a healthcare finance researcher at the Mumbai School of Economics, argues that this model addresses a critical market failure that traditional institutions have ignored for decades. Portfolio diversification by global impact investors has further fueled the growth of this sector, as investors see both social impact and solid risk-adjusted returns compared to traditional fixed income assets. Compliance requirements remain stricter for traditional banks, giving agile fintech firms a competitive edge in this niche market. Critics, however, warn that the rapid growth of unregulated fintech healthcare lending carries hidden risks. Many platforms charge effective annual interest rates above 25%, higher than the caps imposed on traditional bank consumer loans. In 2019, a small fintech lender in Indonesia collapsed after a spike in default rates when a regional dengue outbreak left thousands of borrowers unable to repay their microloans. Regulators have since begun drafting new rules to cap interest rates and increase transparency, to protect vulnerable borrowers from predatory lending practices that could exacerbate, rather than ease, financial strain. Overall, fintech disruption has created tangible benefits for healthcare finance in emerging market economies, addressing a long-standing gap in access to affordable credit for low-income households. While regulatory adjustments are needed to mitigate risks of predatory lending, the core model of using alternative data and mobile infrastructure to expand financial inclusion aligns with broader development goals. As central banks continue to adapt monetary policy and regulatory frameworks to support fintech innovation, this sector is expected to grow steadily through the early 2020s, improving health outcomes and reducing medical poverty across emerging markets.